↓ Skip to main content

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Overview of attention for article published in Annals of Oncology, October 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
2 X users
patent
4 patents
facebook
1 Facebook page

Citations

dimensions_citation
227 Dimensions

Readers on

mendeley
135 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
Published in
Annals of Oncology, October 2013
DOI 10.1093/annonc/mdt412
Pubmed ID
Authors

G. Reid, M.E. Pel, M.B. Kirschner, Y.Y. Cheng, N. Mugridge, J. Weiss, M. Williams, C. Wright, J.J.B. Edelman, M.P. Vallely, B.C. McCaughan, S. Klebe, H. Brahmbhatt, J.A. MacDiarmid, N. van Zandwijk

Abstract

Malignant pleural mesothelioma (MPM) is recalcitrant to treatment and new approaches to therapy are needed. Reduced expression of miR-15/16 in a range of cancer types has suggested a tumour suppressor function for these microRNAs, and re-expression has been shown to inhibit tumour cell proliferation. The miR-15/16 status in MPM is largely unknown.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Netherlands 1 <1%
Canada 1 <1%
Australia 1 <1%
Unknown 131 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 22%
Researcher 18 13%
Student > Master 15 11%
Student > Bachelor 11 8%
Student > Postgraduate 7 5%
Other 24 18%
Unknown 30 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 41 30%
Medicine and Dentistry 20 15%
Agricultural and Biological Sciences 14 10%
Neuroscience 5 4%
Immunology and Microbiology 4 3%
Other 16 12%
Unknown 35 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2022.
All research outputs
#1,438,324
of 25,371,288 outputs
Outputs from Annals of Oncology
#715
of 7,854 outputs
Outputs of similar age
#13,145
of 224,741 outputs
Outputs of similar age from Annals of Oncology
#12
of 127 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,854 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,741 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 127 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.